Mural Oncology plc (MURA) NASDAQ

2.04

+0(+0.00%)

Updated at December 09 09:30AM

Currency In USD

Valuation

Market Cap54.6M
Enterprise Value-52.84M
P/E Ratio-0.24
PEG Ratio0.02
Price/Sales Ratio10.13
Price/Book Ratio0.6
Enterprise/Revenue-10.46
Enterprise/EBITDA0.25

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-42.14
Operating Margin-38.86

Management Effectiveness

Return On Assets-1.68
Return On Equity-1.22

Income Statement

Revenue0
Revenue/Share0.2
Gross Profit-3.51M
EBITDA-125M
Net Income-128.51M
Diluted EPS-7.58

Balance Sheet

Total Cash58.87M
Total Cash/Share4.46
Total Debt3.55M
Total Debt/Equity0.09
Current Ratio2.87
Book Value Per Share3.4

Price History

52-Week Change-35.24
52-Week High4.74
52-Week Low0.95
Moving Average 50 Days2.08
Moving Average 200 Days2.37

Statistics

Average Volume170,823
Shares Outstanding17.34M
% Held by Institutions30.81

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A